theophylline has been researched along with Arterial Obstructive Diseases in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spinella, G | 1 |
| Majorana, M | 1 |
| Creutzig, A | 1 |
| Dau, D | 1 |
| Alexander, K | 1 |
| Benignetti, G | 1 |
| Fabbri, F | 1 |
| Benvenuti, C | 1 |
| Saito, D | 1 |
| Steinhart, CR | 1 |
| Nixon, DG | 1 |
| Olsson, RA | 1 |
| Van Nueten, JM | 1 |
| Wellens, D | 1 |
| Mund-Hoym, WD | 1 |
| Keller, L | 1 |
| Landi, A | 1 |
| Bársony, J | 1 |
| Di Perri, T | 1 |
| Pasini, FL | 1 |
| Pecchi, S | 1 |
| De Franco, V | 1 |
| Damiani, P | 1 |
| Pasqui, AL | 1 |
| Capecchi, PL | 1 |
| Orrico, A | 1 |
| Materazzi, M | 1 |
| Domini, L | 1 |
| Raspanti, D | 1 |
| Cameli, AM | 1 |
| Trapani, M | 1 |
| Dorigo, D | 1 |
| Mazzotta, A | 1 |
| Negro, P | 1 |
| Grossmann, K | 1 |
| Knischka, A | 1 |
| Friedman, S | 1 |
| Golan, A | 1 |
| Shoenfeld, A | 1 |
| Goldman, J | 1 |
| Meyer, MP | 1 |
| Musil, HE | 2 |
| Kunert, W | 1 |
| Lietz, W | 1 |
| Brücknerová, O | 1 |
| Cascio, F | 1 |
| Rossano, C | 1 |
| Testasecca, D | 1 |
| Giugliano, F | 1 |
| Memé, E | 1 |
1 review available for theophylline and Arterial Obstructive Diseases
| Article | Year |
|---|---|
Mechanisms of vasodilatation and antivasoconstriction.
Topics: Actins; Adrenergic alpha-Antagonists; Angiotensin II; Arterial Occlusive Diseases; Bradykinin; Calci | 1979 |
3 trials available for theophylline and Arterial Obstructive Diseases
| Article | Year |
|---|---|
[Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
Topics: Aged; Arterial Occlusive Diseases; Chronic Disease; Clinical Trials as Topic; Humans; Intermittent C | 1983 |
[Conservative treatment of chronic arterial circulation disorders using a combination of adenosine, theophylline, and sodium nicotinate (ATN)].
Topics: Adenosine; Arterial Occlusive Diseases; Clinical Trials as Topic; Drug Combinations; Humans; Nicotin | 1972 |
[Treatment of chronic arterial vascular disorders with Complamin and Complamin retard].
Topics: Adult; Arterial Occlusive Diseases; Chronic Disease; Clinical Trials as Topic; Delayed-Action Prepar | 1973 |
14 other studies available for theophylline and Arterial Obstructive Diseases
| Article | Year |
|---|---|
[Transcutaneous oxygen pressure during intra-arterial infusions].
Topics: Adult; Aged; Arterial Occlusive Diseases; Female; Humans; Infusions, Intra-Arterial; Ischemia; Leg; | 1984 |
[Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
Topics: Aged; Arterial Occlusive Diseases; Blood Viscosity; Female; Humans; Male; Middle Aged; Pentoxifyllin | 1983 |
Intracoronary adenosine deaminase reduces canine myocardial reactive hyperemia.
Topics: Adenosine Deaminase; Animals; Arterial Occlusive Diseases; Blood Pressure; Cardiomyopathies; Cattle; | 1981 |
[Chronic peripheral arterial circulation disorders. Experience with the management of chronic peripheral artertial circulation disorders using Complamine].
Topics: Adult; Aged; Arterial Occlusive Diseases; Female; Humans; Male; Middle Aged; Nicotinic Acids; Theoph | 1978 |
The use of Xavin infusions in obliterating peripheral arterial disorders.
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis Obliterans; Drug Evaluation; Female; Huma | 1975 |
In vivo and in vitro evidence of an adenosine-mediated mechanism of calcium entry blocker activities.
Topics: Adenosine; Arterial Occlusive Diseases; Calcium Channel Blockers; Dipyridamole; Female; Flunarizine; | 1989 |
[Medical treatment of obliterating arteriopathies of the lower limbs with vasoactive drugs].
Topics: Arterial Occlusive Diseases; Drug Evaluation; Follow-Up Studies; Humans; Intermittent Claudication; | 1987 |
[Intra-arterial therapy of arterial occlusive diseases of the extremities].
Topics: Actihaemyl; Adenosine Triphosphate; Anti-Bacterial Agents; Arterial Occlusive Diseases; Drug Therapy | 1987 |
Acute opthalmologic complications during the use of oral contraceptives.
Topics: Adult; Amino Alcohols; Arterial Occlusive Diseases; Contraceptives, Oral; Contraceptives, Oral, Synt | 1974 |
[Treatment of arterial, peripheral and cerebral circulatory disorders. Clinical results using intravenous infusions of complamine].
Topics: Arterial Occlusive Diseases; Cerebrovascular Disorders; Hemodynamics; Hypercholesterolemia; Infusion | 1972 |
[Experiences with the treatment of peripheral vascular diseases with Xavin].
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis Obliterans; Female; Humans; Intermittent Claudic | 1973 |
[Complamin effect in relation to dosage and localisation of vessel occlusion].
Topics: Arterial Occlusive Diseases; Dose-Response Relationship, Drug; Humans; Leg; Nicotinic Acids; Theophy | 1973 |
[Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis Obliterans; Blood Pressure; Chronic Disea | 1973 |
[New administration technic for 7,2-hydroxy-3-(N-hydroxyethyl-N-methylamino)-propyl-1,3-dimethylxanthine, pyridine-3-carboxylate (Complamine). Shock-dose arterioclysis].
Topics: Aged; Aorta, Abdominal; Arterial Occlusive Diseases; Femoral Artery; Humans; Leg Ulcer; Male; Method | 1974 |